Skip to main content
POLAREAN IMAGING PLC logo

POLAREAN IMAGING PLC — Investor Relations & Filings

Ticker · POLX ISIN · GB00BF3DT583 LEI · 213800DGR2BHXJ36OL37 IL Manufacturing
Open in API
Filings indexed 313 across all filing types
Latest filing 2025-12-15 Declaration of Voting R…
Country GB United Kingdom
Listing IL POLX

About POLAREAN IMAGING PLC

https://polarean.com

Polarean Imaging PLC is a medical technology company that develops and commercializes solutions for pulmonary imaging. The company's core focus is its drug-device combination product utilizing hyperpolarized Xenon-129 gas Magnetic Resonance Imaging (XeMRI). This non-invasive, radiation-free technique provides a direct, functional assessment of lung ventilation in a single breath-hold. Polarean developed XENOVIEW™ (xenon Xe 129 hyperpolarized), the first and only hyperpolarized MRI contrast agent approved by the U.S. FDA for evaluating lung ventilation. The technology platform includes the HPX Hyperpolarizer system, specialized gas blends, and dedicated MRI coils, designed to aid in the diagnosis and management of chronic lung diseases.

Recent filings

Filing Released Lang Actions
Result of General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement from Polarean Imaging PLC regarding the 'Result of General Meeting'. It provides a table of voting results for specific resolutions (Cancellation and Re-registration) and details the subsequent delisting from AIM. While it contains information about the meeting results, the primary regulatory purpose of this specific filing is to declare the outcome of shareholder votes, which aligns perfectly with the DVA (Declaration of Voting Results) category.
2025-12-15 English
Chest coil passes Philips compatibility testing
Regulatory Filings Classification · 100% confidence The document is a press release issued via the London Stock Exchange's RNS (Regulatory News Service). It announces a technical milestone regarding the compatibility of Polarean's XENOVIEW 3T Chest Coil with Philips MRI platforms. As this is a general corporate announcement regarding business operations and product development that does not fit into specific categories like financial reports, M&A, or director dealings, it is classified as a Regulatory Filing (RNS).
2025-12-01 English
First Xenon Hyperpolariser in Asia
Regulatory Filings Classification · 100% confidence The document is a press release distributed via the London Stock Exchange's RNS (Regulatory News Service). It announces a specific business development: the first installation of the company's Xenon MRI technology in Asia (Taiwan). It does not fit into specific categories like financial reports, dividend announcements, or director dealings. As it is a general corporate announcement regarding business operations and strategic partnerships, it falls under the 'Regulatory Filings' (RNS) category.
2025-11-25 English
Korean distributor agreement with DK Healthcare
Regulatory Filings Classification · 100% confidence The document is a regulatory announcement (RNS) from Polarean Imaging PLC regarding a new commercial distribution agreement in South Korea. It does not fit into specific categories like financial reports, proxy statements, or dividend notices. As it is a general corporate announcement regarding business operations and partnerships, it falls under the 'Regulatory Filings' (RNS) category.
2025-11-24 English
Proposed Cancellation of Admission & Notice of GM
Delisting Announcement Classification · 100% confidence The document is an official announcement from Polarean Imaging PLC regarding the proposed cancellation of its admission to trading on the AIM market and its subsequent re-registration as a private limited company. It includes a notice of a General Meeting to vote on these proposals. While it contains extracts from a circular, the document itself functions as a regulatory announcement (RNS) informing the market of these corporate actions and the upcoming shareholder vote. It does not fit the criteria for a full proxy statement (which would be the full circular itself) or a simple report publication announcement, as it provides the core details of the strategic shift directly.
2025-11-14 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the regulatory standard in the UK for disclosing changes in significant share ownership. It explicitly details the acquisition or disposal of voting rights, identifies the shareholder (Maven Capital Partners UK LLP), and provides the resulting percentage of voting rights. This aligns perfectly with the definition of a Major Shareholding Notification.
2025-10-27 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.